Serena Slavenburg

Summary

Affiliation: Radboud University Nijmegen Medical Centre
Country: The Netherlands

Publications

  1. ncbi request reprint Prevalence of hepatitis C in the general population in the Netherlands
    S Slavenburg
    Department of Medicine, Division of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre, The Netherlands
    Neth J Med 66:13-7. 2008
  2. pmc Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature
    Serena Slavenburg
    Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    Dig Dis Sci 55:579-85. 2010
  3. ncbi request reprint Current clinical care compared with new Dutch guidelines for hepatitis C treatment
    S Slavenburg
    Departments of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Neth J Med 67:177-81. 2009
  4. doi request reprint Optimal length of antiviral therapy in patients with hepatitis C virus genotypes 2 and 3: a meta-analysis
    Serena Slavenburg
    Department of Medicine, Division of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Antivir Ther 14:1139-48. 2009
  5. doi request reprint Ribavirin plasma concentration measurements in patients with hepatitis C: early ribavirin concentrations predict steady-state concentrations
    Serena Slavenburg
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    Ther Drug Monit 33:40-4. 2011
  6. ncbi request reprint Rationale and design of the virological response and ribavirin dosage (VIRID) study in hepatitis
    J F Bergmann
    Neth J Med 66:44-5. 2008

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Prevalence of hepatitis C in the general population in the Netherlands
    S Slavenburg
    Department of Medicine, Division of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre, The Netherlands
    Neth J Med 66:13-7. 2008
    ..The prevalence in the general Dutch population is unknown, although it appears to be very low in screened blood donors (0.0169%)...
  2. pmc Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature
    Serena Slavenburg
    Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    Dig Dis Sci 55:579-85. 2010
    ..In most cases therapy was discontinued and steroids were started. Interferon-induced pneumonitis during HCV treatment is a severe complication and should be recognized in order to prevent further pulmonary damage and/or death...
  3. ncbi request reprint Current clinical care compared with new Dutch guidelines for hepatitis C treatment
    S Slavenburg
    Departments of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Neth J Med 67:177-81. 2009
    ..Before these guidelines were published and implemented we (1) studied the current clinical care of HCV patients among Dutch physicians, and (2) identified areas for future refinement in the current treatment...
  4. doi request reprint Optimal length of antiviral therapy in patients with hepatitis C virus genotypes 2 and 3: a meta-analysis
    Serena Slavenburg
    Department of Medicine, Division of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Antivir Ther 14:1139-48. 2009
    ..Several trials investigated whether shorter treatment duration is equally effective in achieving sustained virological response (SVR). Our aim was to determine the optimal length of treatment in patients with HCV genotypes 2 and 3...
  5. doi request reprint Ribavirin plasma concentration measurements in patients with hepatitis C: early ribavirin concentrations predict steady-state concentrations
    Serena Slavenburg
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    Ther Drug Monit 33:40-4. 2011
    ..Monitoring ribavirin concentration is suggested in the literature, but it is unclear at what time point during treatment plasma ribavirin concentrations should be monitored...
  6. ncbi request reprint Rationale and design of the virological response and ribavirin dosage (VIRID) study in hepatitis
    J F Bergmann
    Neth J Med 66:44-5. 2008